UK contract research organization hVIVO (AIM: HVO) is gearing up to test an inhaled antiviral candidate, IN-002, for ...

Swiss generic and biosimilars drugmaker Sandoz today revealed that Francisco Ballester, president Region International and a ...

The UK’s Medicines and Healthcare products Regulatory Agency (MHRA) has launched a consultation on regulatory guidance for ...

At Sweden’s annual life science conference, stakeholders from healthcare, academia, and industry discussed implementing the ...

The European Federation of Industries and Associations (EFPIA) has welcomed the publication of the Competitiveness Compass ...

Faisal Sukhtian has been appointed as chairman of the board of directors at Outlook Therapeutics, effective immediately.

The US Food and Drug Administration (FDA) has approved Avtozma (CT-P47, tocilizumab-anoh) in both an intravenous (IV) and subcutaneous (SC) formulation as a biosimilar to Actemra, developed by South ...

Japan’s Eisai and US partner Biogen have announced today update on the ongoing regulatory review of the Marketing Authorization Application for lecanemab (trade name Leqembi) as a treatment for early ...

Among significant research news last week, US biotech Allakos reported that it was dropping development of its urticaria ...

Japanese drugmaker Daiichi Sankyo has appointed Hiroyuki Okuzawa to succeed Sunao Manabe, as chief executive (CEO), effective ...

Days after the European Commission (EC) granted approval, the UK’s Medicines and Healthcare Regulatory Agency (MHRA) has ...

A clinical-stage biopharma company developing therapeutic product candidates for metabolic diseases, such as obesity, by ...